It was a Merger Monday for the Biotech sector – with two deals being announced.
Horizon Pharma plc (HZNP) is all set to acquire Hyperion Therapeutics Inc. (HPTX) for $46.00 per share or $1.1 billion in cash. Another deal of the day is the acquisition of Auspex Pharmaceuticals, Inc. (ASPX) by Teva Pharmaceutical Industries Ltd. (TEVA) for $101.00 per share in cash.